tenk.fyi

ImmunityBio, Inc.

IBRXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$113.3M

668.3% YoY

Net Income

-$351.4M

15.0% YoY

EPS

$-0.38

38.7% YoY

Cash

$88.3M

38.4% YoY

FY 2025 · As of 2025-12-31